Stock Earnings

Question 1

What are Organogenesis Holdings Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Organogenesis Holdings Inc has a total asset of $497, Net loss of $0

Question 2

What are the key financial ratios for ORGO?

Accepted Answer

Organogenesis Holdings Inc's Current ratio is 4.43, has a Net margin is 0, sales per share of $3.66.

Question 3

How is Organogenesis Holdings Inc's revenue broken down by segment or geography?

Accepted Answer

Organogenesis Holdings Inc largest revenue segment is Advanced Wound Care, at a revenue of 453,639,000 in the most earnings release.For geography, United States is the primary market for Organogenesis Holdings Inc, at a revenue of 482,043,000.

Question 4

Is Organogenesis Holdings Inc profitable?

Accepted Answer

no, according to the latest financial statements, Organogenesis Holdings Inc has a net loss of $0

Question 5

Does Organogenesis Holdings Inc have any liabilities?

Accepted Answer

yes, Organogenesis Holdings Inc has liability of 112

Question 6

How many outstanding shares for Organogenesis Holdings Inc?

Accepted Answer

Organogenesis Holdings Inc has a total outstanding shares of 125.73

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	429	482	433	450	468	338
Revenue Growth (YoY)	-4%	11%	-4%	-4%	38%	30%
Cost of Revenue	109	115	106	105	114	87
Gross Profit	320	366	326	345	353	251
Selling, General & Admin	291	294	269	283	250	204
Research & Development	42	50	44	39	30	20
Operating Expenses	334	344	314	323	280	224
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-21	-2	10	20	63	17
Income Tax Expense	-13	-3	5	4	-31	0
Net Income	-15	0	4	15	94	17
Net Income Growth	-6%	-100%	-73%	-84%	453%	-144%
Shares Outstanding (Diluted)	126.85	131.67	132.74	132.4	133.7	111.4
Shares Change (YoY)	-4%	-1%	0%	-1%	20%	20%
EPS (Diluted)	-0.12	0	0.03	0.12	0.71	0.15
EPS Growth	1%	-119%	-69%	-83%	373%	-136%
Free Cash Flow	-46	4	6	-9	30	-12
Free Cash Flow Per Share	-0.36	0.03	0.04	-0.06	0.22	-0.1
Gross Margin	74.59%	75.93%	75.28%	76.66%	75.42%	74.26%
Operating Margin	-3.26%	4.35%	2.77%	4.88%	15.38%	7.69%
Profit Margin	-3.49%	0%	0.92%	3.33%	20.08%	5.02%
Free Cash Flow Margin	-10.72%	0.82%	1.38%	-2%	6.41%	-3.55%
EBITDA	3	38	27	32	82	34
EBITDA Margin	0.69%	7.88%	6.23%	7.11%	17.52%	10.05%
D&A For EBITDA	17	17	15	10	10	8
EBIT	-14	21	12	22	72	26
EBIT Margin	-3.26%	4.35%	2.77%	4.88%	15.38%	7.69%
Effective Tax Rate	61.9%	150%	50%	20%	-49.2%	0%

Organogenesis Holdings Inc (ORGO) Price

ORGO Stock Price Chart

ORGO Income

Follow-Up Questions